1,4-naphthoquinone has been researched along with Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araújo, DA; Camara, CA; Coulidiati, TH; Dantas, BB; de Oliveira, RN; do Nascimento, WS; Faheina-Martins, GV; Gomes, ER; Gonçalves, JC; Lara, A; Oliveira, EJ | 1 |
Bacelar, TS; Buarque, CD; Castro, CP; Costa, PR; da Silva, AJ; Fernandes, RF; Maia, RC; Netto, CD; Rumjanek, VM; Salustiano, EJ | 1 |
2 other study(ies) available for 1,4-naphthoquinone and Leukemia
Article | Year |
---|---|
Distinct effects of novel naphtoquinone-based triazoles in human leukaemic cell lines.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Proteins; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Inhibitory Concentration 50; K562 Cells; Leukemia; Membrane Potential, Mitochondrial; Molecular Structure; Naphthoquinones; Oxidative Stress; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints; Structure-Activity Relationship; Triazoles | 2015 |
Comparison of the cytotoxic effect of lapachol, alpha-lapachone and pentacyclic 1,4-naphthoquinones on human leukemic cells.
Topics: Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Leukemia; Leukocytes, Mononuclear; Mitomycin; Naphthoquinones | 2010 |